HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Involvement of the urogenital tract in patients with five or more separate malignant neoplasms. Case and review.

Abstract
Occurrence of metachronous primary malignant neoplasms (PMN) in five or more different organs and tissue of the same patient is a very rare event. The present paper reports on a female patient who experienced Hodgkin's disease of nodular sclerotic type (stage IV), carcinoma of the cervix uteri (stage I), adenocarcinoma of the rectum (Dukes A), and a well-differentiated adenocarcinoma of the stomach (pT1) before she demonstrated multicentric transitional cell carcinoma of the renal pelvis and ureter (pT3b G2-3) and of the bladder (pTa G2). Although an increased inherent predisposition of the patient to exhibit those neoplasms, similar to Lynch syndrome II, is to be discussed, her previous treatments with cyclophosphamide and external radiotherapy are likely to explain at least the occurrence of urothelial cancer. However, a report on renal pelvis and ureteral cancer induced by cyclophosphamide or irradiation is a rarity in itself.
AuthorsD Rohde, G Jakse
JournalEuropean urology (Eur Urol) Vol. 34 Issue 6 Pg. 512-7 (Dec 1998) ISSN: 0302-2838 [Print] Switzerland
PMID9831794 (Publication Type: Case Reports, Journal Article, Review)
Topics
  • Adenocarcinoma (genetics, pathology, therapy)
  • Adult
  • Aged
  • Carcinoma, Transitional Cell (genetics, pathology, therapy)
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Genetic Predisposition to Disease
  • Hodgkin Disease (genetics, pathology, therapy)
  • Humans
  • Middle Aged
  • Neoplasms, Multiple Primary (genetics, pathology, therapy)
  • Retrospective Studies
  • Urogenital Neoplasms (genetics, pathology, therapy)
  • Urography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: